New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Queen's University · GlaxoSmithKline (Belgium) · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
29,307
total citations
- FWCI
- 224.97
- Percentile
- 100%
- References
- 26
Citations per year
Authors
16- EEE. EisenhauerCorresponding
Queen's University
- PTP. Therasse
GlaxoSmithKline (Belgium), GlaxoSmithKline (United Kingdom)
- JBJan Bogaerts
European Organisation for Research and Treatment of Cancer
- LHLawrence H. Schwartz
Memorial Sloan Kettering Cancer Center
- DJDaniel J. Sargent
Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic in Arizona
Topics & keywords
Topics
Keywords
- Guideline
- Response Evaluation Criteria in Solid Tumors
- Medicine
- Clinical trial
- Clinical endpoint
- Pathological
- Disease
- Target lesion
No related works found for this paper.